Bath & Body Works, Inc. (NYSE:BBWI) Shares Purchased by Natixis Advisors LLC

Natixis Advisors LLC raised its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 46.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 89,460 shares of the company's stock after buying an additional 28,186 shares during the period. Natixis Advisors LLC's holdings in Bath & Body Works were worth $3,468,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Bath & Body Works by 32.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 52,784 shares of the company's stock worth $2,046,000 after purchasing an additional 12,964 shares in the last quarter. Wellington Management Group LLP bought a new position in shares of Bath & Body Works during the 3rd quarter worth $8,129,000. Forest Avenue Capital Management LP grew its position in shares of Bath & Body Works by 19.1% during the 3rd quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company's stock worth $46,851,000 after buying an additional 235,173 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Bath & Body Works by 13.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company's stock valued at $66,088,000 after buying an additional 195,813 shares during the period. Finally, iA Global Asset Management Inc. raised its holdings in shares of Bath & Body Works by 1,078.2% in the third quarter. iA Global Asset Management Inc. now owns 49,331 shares of the company's stock valued at $1,575,000 after acquiring an additional 45,144 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Ratings Changes

Several research analysts have issued reports on BBWI shares. TD Cowen increased their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a "buy" rating in a report on Thursday, December 12th. JPMorgan Chase & Co. set a $47.00 price target on shares of Bath & Body Works in a research report on Thursday, February 27th. Argus reissued a "hold" rating on shares of Bath & Body Works in a report on Friday, January 10th. Robert W. Baird upped their target price on Bath & Body Works from $45.00 to $47.00 and gave the stock an "outperform" rating in a report on Friday, February 28th. Finally, Citigroup upgraded Bath & Body Works from a "neutral" rating to a "buy" rating and lifted their price target for the company from $40.00 to $48.00 in a report on Friday, February 28th. Five equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $45.06.

Bath & Body Works Price Performance

Bath & Body Works stock traded down $0.36 during mid-day trading on Wednesday, reaching $31.84. 4,626,176 shares of the company traded hands, compared to its average volume of 4,895,396. The company has a market capitalization of $6.82 billion, a price-to-earnings ratio of 7.77, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The firm's fifty day moving average is $35.52 and its two-hundred day moving average is $34.03.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to analysts' expectations of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were paid a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.51%. Bath & Body Works's payout ratio is currently 21.98%.

Bath & Body Works announced that its board has approved a stock buyback program on Thursday, February 27th that authorizes the company to repurchase $500.00 million in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 6.4% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its stock is undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.